11.07.2015 Views

Drug Resistance in Tuberculosis and Its Public Health Management ...

Drug Resistance in Tuberculosis and Its Public Health Management ...

Drug Resistance in Tuberculosis and Its Public Health Management ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Drug</strong> <strong>Resistance</strong> <strong>in</strong> <strong>Tuberculosis</strong><strong>and</strong> <strong>Its</strong> <strong>Public</strong> <strong>Health</strong> <strong>Management</strong>Dr. Paul NunnWhy is plann<strong>in</strong>g for MDR-TBtreatment programmes important?• MDR-TB treatment is difficult, complex, time-consum<strong>in</strong>g<strong>and</strong> expensive – much more so than drug sensitive TB• Provision of reliable treatment to hundreds of patientsfor ~2 years on a national scale requires enormouscoord<strong>in</strong>ation of multiple players – <strong>and</strong> is thus a majorplann<strong>in</strong>g exercise25http://www.path.org/publications/detail.php?i=1678Essential pr<strong>in</strong>ciples of care for MDR-TBstrengthen basic TB controlPolitical commitment to implement objectives of the responsewith adequate budget to startMicrobiological diagnosis (culture, drug susceptibility test by a qualityassuredlaboratory) <strong>and</strong> monitor<strong>in</strong>g of response to treatmentCollaboration with HIV programmePatient-centred approach for direct observation of treatmenton out-patient or hospitalised basisCare under proper <strong>in</strong>fection control conditions26Quality assured second-l<strong>in</strong>e anti-TB drugs, meet<strong>in</strong>g at leastWHO-GMP st<strong>and</strong>ardsRecord<strong>in</strong>g <strong>and</strong> report<strong>in</strong>g for monitor<strong>in</strong>g <strong>and</strong> evaluationEssential elements <strong>in</strong> plann<strong>in</strong>g the strengthen<strong>in</strong>gof basic TB control through MDR-TB managementEstimate burdenMeasure diagnostic capacity <strong>in</strong> place <strong>and</strong> def<strong>in</strong>e gapsDecide models of care (hospitalisation, outpatient)Ensure <strong>in</strong>fection control measures <strong>in</strong> place <strong>and</strong> def<strong>in</strong>e gapsEnsure social support networkPlan drug procurement – second-l<strong>in</strong>e anti-TB drugs <strong>and</strong> those for adverse effectsSet up record<strong>in</strong>g <strong>and</strong> report<strong>in</strong>g systemEnsure workforce <strong>in</strong> place <strong>and</strong> def<strong>in</strong>e gapsSet up staff development <strong>and</strong> tra<strong>in</strong><strong>in</strong>gWrite national guidel<strong>in</strong>es <strong>and</strong> manual of operationsConsider operational research agendaBudget <strong>and</strong> f<strong>in</strong>anc<strong>in</strong>g27The screen versions of these slides have full details of copyright <strong>and</strong> acknowledgements9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!